Super Drugs for Super Bugs

  Super Drugs for Super Bugs November-December 2016 Harvard Magazine By Erin O’Donnell Last spring brought alarming reports of the first known case of a germ resistant to colistin, considered an antibiotic of last resort. The bug, a strain of E. coli, was...

Building a Better Haystack

Building a Better Haystack June 2016 Biocentury Innovations By Selina Koch A year after raising $22 million in a series A round, Macrolide Pharmaceuticals Inc. has disclosed details of how its antibiotic discovery platform is creating a library of compounds with...